BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wagner B, Drel V, Gorin Y. Pathophysiology of gadolinium-associated systemic fibrosis. Am J Physiol Renal Physiol 2016;311:F1-F11. [PMID: 27147669 DOI: 10.1152/ajprenal.00166.2016] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 6.2] [Reference Citation Analysis]
Number Citing Articles
1 Do C, Drel V, Tan C, Lee D, Wagner B. Nephrogenic Systemic Fibrosis Is Mediated by Myeloid C-C Chemokine Receptor 2. J Invest Dermatol 2019;139:2134-2143.e2. [PMID: 30978353 DOI: 10.1016/j.jid.2019.03.1145] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
2 Do C, DeAguero J, Brearley A, Trejo X, Howard T, Escobar GP, Wagner B. Gadolinium-Based Contrast Agent Use, Their Safety, and Practice Evolution. Kidney360 2020;1:561-8. [PMID: 34423308 DOI: 10.34067/kid.0000272019] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
3 Unruh C, Van Bavel N, Anikovskiy M, Prenner EJ. Benefits and Detriments of Gadolinium from Medical Advances to Health and Ecological Risks. Molecules 2020;25:E5762. [PMID: 33297578 DOI: 10.3390/molecules25235762] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Pesapane F, Acquasanta M, Meo RD, Agazzi GM, Tantrige P, Codari M, Schiaffino S, Patella F, Esseridou A, Sardanelli F. Comparison of Sensitivity and Specificity of Biparametric versus Multiparametric Prostate MRI in the Detection of Prostate Cancer in 431 Men with Elevated Prostate-Specific Antigen Levels. Diagnostics (Basel) 2021;11:1223. [PMID: 34359307 DOI: 10.3390/diagnostics11071223] [Reference Citation Analysis]
5 Bäuerle T, Saake M, Uder M. Gadolinium-based contrast agents: What we learned from acute adverse events, nephrogenic systemic fibrosis and brain retention. Rofo 2021;193:1010-8. [PMID: 33348385 DOI: 10.1055/a-1328-3177] [Reference Citation Analysis]
6 Lunyera J, Mohottige D, Alexopoulos AS, Campbell H, Cameron CB, Sagalla N, Amrhein TJ, Crowley MJ, Dietch JR, Gordon AM, Kosinski AS, Cantrell S, Williams JW Jr, Gierisch JM, Ear B, Goldstein KM. Risk for Nephrogenic Systemic Fibrosis After Exposure to Newer Gadolinium Agents: A Systematic Review. Ann Intern Med 2020;173:110-9. [PMID: 32568573 DOI: 10.7326/M20-0299] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
7 Li J, An C, Kang L, Mitch WE, Wang Y. Recent Advances in Magnetic Resonance Imaging Assessment of Renal Fibrosis. Adv Chronic Kidney Dis 2017;24:150-3. [PMID: 28501077 DOI: 10.1053/j.ackd.2017.03.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
8 Piera-Velazquez S, Wermuth PJ, Gomez-Reino JJ, Varga J, Jimenez SA. Chemical exposure-induced systemic fibrosing disorders: Novel insights into systemic sclerosis etiology and pathogenesis. Semin Arthritis Rheum 2020;50:1226-37. [PMID: 33059296 DOI: 10.1016/j.semarthrit.2020.09.003] [Reference Citation Analysis]
9 Pesapane F, Patella F, Fumarola EM, Zanchetta E, Floridi C, Carrafiello G, Standaert C. The prostate cancer focal therapy. Gland Surg 2018;7:89-102. [PMID: 29770305 DOI: 10.21037/gs.2017.11.08] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
10 Leyba K, Wagner B. Gadolinium-based contrast agents: why nephrologists need to be concerned. Curr Opin Nephrol Hypertens 2019;28:154-62. [PMID: 30531473 DOI: 10.1097/MNH.0000000000000475] [Cited by in Crossref: 13] [Cited by in F6Publishing: 7] [Article Influence: 13.0] [Reference Citation Analysis]
11 Alfano G, Fontana F, Ferrari A, Solazzo A, Perrone R, Giaroni F, Torricelli P, Cappelli G. Incidence of nephrogenic systemic fibrosis after administration of gadoteric acid in patients on renal replacement treatment. Magn Reson Imaging 2020;70:1-4. [PMID: 32112811 DOI: 10.1016/j.mri.2020.02.012] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 10.0] [Reference Citation Analysis]
12 Rudnick MR, Wahba IM, Leonberg-Yoo AK, Miskulin D, Litt HI. Risks and Options With Gadolinium-Based Contrast Agents in Patients With CKD: A Review. Am J Kidney Dis 2021;77:517-28. [PMID: 32861792 DOI: 10.1053/j.ajkd.2020.07.012] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Takahashi EA, Kallmes DF, Mara KC, Harmsen WS, Misra S. Nephrotoxicity of gadolinium-based contrast in the setting of renal artery intervention: retrospective analysis with 10-year follow-up. Diagn Interv Radiol 2018;24:378-84. [PMID: 30406762 DOI: 10.5152/dir.2018.18172] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 3.5] [Reference Citation Analysis]
14 Do C, Ford B, Lee DY, Tan C, Escobar P, Wagner B. Gadolinium-based contrast agents: Stimulators of myeloid-induced renal fibrosis and major metabolic disruptors. Toxicol Appl Pharmacol 2019;375:32-45. [PMID: 31082427 DOI: 10.1016/j.taap.2019.05.009] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 3.0] [Reference Citation Analysis]
15 Hazelton JM, Chiu MK, Abujudeh HH. Nephrogenic Systemic Fibrosis: A Review of History, Pathophysiology, and Current Guidelines. Curr Radiol Rep 2019;7. [DOI: 10.1007/s40134-019-0312-1] [Cited by in Crossref: 8] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
16 Radbruch A. The Gadolinium Deposition Debate and the Streetlight Effect: Should We Really Focus on the Brain? Radiology 2020;297:417-8. [PMID: 32813600 DOI: 10.1148/radiol.2020203143] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
17 Martino F, Amici G, Rosner M, Ronco C, Novara G. Gadolinium-Based Contrast Media Nephrotoxicity in Kidney Impairment: The Physio-Pathological Conditions for the Perfect Murder. J Clin Med 2021;10:E271. [PMID: 33450989 DOI: 10.3390/jcm10020271] [Reference Citation Analysis]
18 Bruno F, DeAguero J, Do C, Lee DY, Tan C, Escobar GP, Wagner B. Overlapping roles of NADPH oxidase 4 for diabetic and gadolinium-based contrast agent-induced systemic fibrosis. Am J Physiol Renal Physiol 2021;320:F617-27. [PMID: 33615889 DOI: 10.1152/ajprenal.00456.2020] [Reference Citation Analysis]
19 Wang S, Li J, Zhu D, Hua T, Zhao B. Contrast-enhanced magnetic resonance (MR) T1 mapping with low-dose gadolinium-diethylenetriamine pentaacetic acid (Gd-DTPA) is promising in identifying clear cell renal cell carcinoma histopathological grade and differentiating fat-poor angiomyolipoma. Quant Imaging Med Surg 2020;10:988-98. [PMID: 32489923 DOI: 10.21037/qims-19-723] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
20 Yee J. Prophylactic Hemodialysis for Protection Against Gadolinium-Induced Nephrogenic Systemic Fibrosis: A Doll's House. Advances in Chronic Kidney Disease 2017;24:133-5. [DOI: 10.1053/j.ackd.2017.03.007] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
21 Osterode W, Falkenberg G, Regele H. Gadolinium distribution in kidney tissue determined and quantified by micro synchrotron X-ray fluorescence. Biometals 2021;34:341-50. [PMID: 33486677 DOI: 10.1007/s10534-020-00284-8] [Reference Citation Analysis]
22 Soikkeli M, Horkka K, Moilanen JO, Timonen M, Kavakka J, Heikkinen S. Synthesis, Stability and Relaxivity of TEEPO-Met: An Organic Radical as a Potential Tumour Targeting Contrast Agent for Magnetic Resonance Imaging. Molecules 2018;23:E1034. [PMID: 29702628 DOI: 10.3390/molecules23051034] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 3.3] [Reference Citation Analysis]
23 Leisman S. Radiocontrast Toxicity. Adv Chronic Kidney Dis 2020;27:50-5. [PMID: 32147002 DOI: 10.1053/j.ackd.2019.08.002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Dávila-jiménez MM, Elizalde-gonzález MP, Guerrero-morales MA, Mattusch J. Preparation, characterization, and application of TiO2/Carbon composite: Adsorption, desorption and photocatalysis of Gd-DOTA. Process Safety and Environmental Protection 2018;120:195-205. [DOI: 10.1016/j.psep.2018.09.012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
25 Martí-bonmatí L, Martí-bonmatí E. Retención de compuestos de gadolinio usados en resonancia magnética: revisión crítica y recomendaciones de las agencias regulatorias. Radiología 2017;59:469-77. [DOI: 10.1016/j.rx.2017.09.007] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
26 Pesapane F, Patella F, Fumarola EM, Panella S, Ierardi AM, Pompili GG, Franceschelli G, Angileri SA, Magenta Biasina A, Carrafiello G. Intravoxel Incoherent Motion (IVIM) Diffusion Weighted Imaging (DWI) in the Periferic Prostate Cancer Detection and Stratification. Med Oncol 2017;34:35. [PMID: 28144814 DOI: 10.1007/s12032-017-0892-7] [Cited by in Crossref: 28] [Cited by in F6Publishing: 30] [Article Influence: 7.0] [Reference Citation Analysis]
27 Layne KA, Raja K, Dargan PI, Wood DM. Gadolinium Concentrations in Biological Matrices From Patients Exposed to Gadolinium-Based Contrast Agents. Invest Radiol 2021;56:458-64. [PMID: 34086014 DOI: 10.1097/RLI.0000000000000762] [Reference Citation Analysis]
28 Sigel H, Sigel A. The bio-relevant metals of the periodic table of the elements. Zeitschrift für Naturforschung B 2019;74:461-71. [DOI: 10.1515/znb-2019-0056] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]